These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 16402263)
1. The role of nanobacteria in urologic disease. Wood HM; Shoskes DA World J Urol; 2006 Feb; 24(1):51-4. PubMed ID: 16402263 [TBL] [Abstract][Full Text] [Related]
2. Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience. Shoskes DA; Thomas KD; Gomez E J Urol; 2005 Feb; 173(2):474-7. PubMed ID: 15643213 [TBL] [Abstract][Full Text] [Related]
3. Prostatitis: the role of antibiotic treatment. Wagenlehner FM; Naber KG World J Urol; 2003 Jun; 21(2):105-8. PubMed ID: 12687400 [TBL] [Abstract][Full Text] [Related]
4. Lithogenesis: induction of renal calcifications by nanobacteria. Shiekh FA; Khullar M; Singh SK Urol Res; 2006 Feb; 34(1):53-7. PubMed ID: 16425019 [TBL] [Abstract][Full Text] [Related]
5. The Urinary Tract Microbiome in Health and Disease. Aragón IM; Herrera-Imbroda B; Queipo-Ortuño MI; Castillo E; Del Moral JS; Gómez-Millán J; Yucel G; Lara MF Eur Urol Focus; 2018 Jan; 4(1):128-138. PubMed ID: 28753805 [TBL] [Abstract][Full Text] [Related]
6. Detection of nanobacteria infection in type III prostatitis. Zhou Z; Hong L; Shen X; Rao X; Jin X; Lu G; Li L; Xiong E; Li W; Zhang J; Chen Z; Pan J; Song B Urology; 2008 Jun; 71(6):1091-5. PubMed ID: 18538692 [TBL] [Abstract][Full Text] [Related]
7. Nanobacteria: a possible etiology for type III prostatitis. Shen X; Ming A; Li X; Zhou Z; Song B J Urol; 2010 Jul; 184(1):364-9. PubMed ID: 20488493 [TBL] [Abstract][Full Text] [Related]
8. Bacteria in the chronic prostatitis-chronic pelvic pain syndrome: molecular approaches to critical research questions. Krieger JN; Riley DE J Urol; 2002 Jun; 167(6):2574-83. PubMed ID: 11992091 [TBL] [Abstract][Full Text] [Related]
9. Use of antibiotics in chronic prostatitis syndromes. Shoskes DA Can J Urol; 2001 Jun; 8 Suppl 1():24-8. PubMed ID: 11442994 [TBL] [Abstract][Full Text] [Related]
10. A hypothesis for anti-nanobacteria effects of gallium with observations from treating kidney disease. Eby GA Med Hypotheses; 2008 Oct; 71(4):584-90. PubMed ID: 18579317 [TBL] [Abstract][Full Text] [Related]
11. [Clinical studies against chronic prostatitis and prostatitis-like syndrome (1). Clinico-statistical observation]. Ikeuchi T Hinyokika Kiyo; 1988 Mar; 34(3):446-52. PubMed ID: 3389292 [TBL] [Abstract][Full Text] [Related]
12. [Cultivation and morphology of nanobacteria in sera of patients with kidney calculi]. Chen L; Huang XB; Xu QQ; Li JX; Jia XJ; Wang XF Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):443-6. PubMed ID: 20721260 [TBL] [Abstract][Full Text] [Related]
14. Is there any relation of nanobacteria with periodontal diseases? Demir T Med Hypotheses; 2008; 70(1):36-9. PubMed ID: 17587506 [TBL] [Abstract][Full Text] [Related]
15. [Isolation of Mycoplasma and L-form bacteria in inflammatory diseases of the organs of the urogenital system]. Sukhodol'skaia AE; Rudenko AV Urol Nefrol (Mosk); 1973; 38(2):17-9. PubMed ID: 4756557 [No Abstract] [Full Text] [Related]
19. [The most frequent urologic diseases in population of West Pomoravlje]. Bekcić N Srp Arh Celok Lek; 1969 Apr; 97(4):431-5. PubMed ID: 5198763 [No Abstract] [Full Text] [Related]
20. Editorial comment on: Chronic pelvic pain and lower urinary tract symptoms in both sexes: analysis of 2749 participants of an urban health screening project. Zaak D Eur Urol; 2009 Feb; 55(2):507. PubMed ID: 18395966 [No Abstract] [Full Text] [Related] [Next] [New Search]